Wednesday, December 2, 2009
Antigenics Announces Expansion of Its QS-21 License Agreement - Reuters
Antigenics Announces Expansion of Its QS-21 License AgreementReutersAbout Alzheimer's Disease Alzheimer`s disease is a progressive and fatal brain disease. According to the Alzheimer`s Association as many as 5.3 million ...and more »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment